{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T05:39:45Z","timestamp":1780378785038,"version":"3.54.1"},"reference-count":31,"publisher":"European Respiratory Society (ERS)","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.ersjournals.com\/user-licence"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2023,2,25]]},"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1183\/13993003.00216-2023","type":"journal-article","created":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T14:25:17Z","timestamp":1680359117000},"page":"2300216","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["The effects of elexacaftor\/tezacaftor\/ivacaftor beyond the epithelium: spurring macrophages to fight infections"],"prefix":"10.1183","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2149-4057","authenticated-orcid":false,"given":"Emanuela M.","family":"Bruscia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2023,4,1]]},"reference":[{"key":"2024102012242280000_61.4.2300216.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908639"},{"key":"2024102012242280000_61.4.2300216.2","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.ccm.2022.06.007","article-title":"The Impact of highly effective modulator therapy on cystic fibrosis microbiology and inflammation","volume":"43","author":"Caverly","year":"2022","journal-title":"Clin Chest Med"},{"key":"2024102012242280000_61.4.2300216.3","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.ccm.2022.06.004","article-title":"Update on innate and adaptive immunity in cystic fibrosis","volume":"43","author":"Bruscia","year":"2022","journal-title":"Clin Chest Med"},{"key":"2024102012242280000_61.4.2300216.4","doi-asserted-by":"publisher","DOI":"10.1159\/000446825"},{"key":"2024102012242280000_61.4.2300216.5","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.03502-2020"},{"key":"2024102012242280000_61.4.2300216.6","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00725-2022"},{"key":"2024102012242280000_61.4.2300216.7","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02861-2021"},{"key":"2024102012242280000_61.4.2300216.8","doi-asserted-by":"crossref","first-page":"L432","DOI":"10.1152\/ajplung.00461.2017","article-title":"Lumacaftor (VX-809) restores the ability of CF macrophages to phagocytose and kill Pseudomonas aeruginosa","volume":"314","author":"Barnaby","year":"2018","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2024102012242280000_61.4.2300216.9","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1502609"},{"key":"2024102012242280000_61.4.2300216.10","doi-asserted-by":"crossref","first-page":"819554","DOI":"10.3389\/fcimb.2022.819554","article-title":"CFTR modulators restore acidification of autophago-lysosomes and bacterial clearance in cystic fibrosis macrophages","volume":"12","author":"Badr","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"2024102012242280000_61.4.2300216.11","doi-asserted-by":"publisher","DOI":"10.1038\/ncb1456"},{"key":"2024102012242280000_61.4.2300216.12","first-page":"3125","article-title":"CFTR-independent phagosomal acidification in macrophages","volume":"20","author":"Haggie","year":"2007","journal-title":"J Biol Chem"},{"key":"2024102012242280000_61.4.2300216.13","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.E09-01-0061"},{"key":"2024102012242280000_61.4.2300216.14","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.immuni.2017.11.010","article-title":"Cystic fibrosis transmembrane conductance regulator attaches tumor suppressor PTEN to the membrane and promotes anti Pseudomonas aeruginosa immunity","volume":"47","author":"Riquelme","year":"2017","journal-title":"Immunity"},{"key":"2024102012242280000_61.4.2300216.15","doi-asserted-by":"crossref","first-page":"10882","DOI":"10.1038\/s41598-017-11012-7","article-title":"Ezrin links CFTR to TLR4 signaling to orchestrate anti-bacterial immune response in macrophages","volume":"7","author":"Di Pietro","year":"2017","journal-title":"Sci Rep"},{"key":"2024102012242280000_61.4.2300216.16","doi-asserted-by":"crossref","first-page":"e21185","DOI":"10.1096\/fj.201903210R","article-title":"A SNARE protein Syntaxin 17 captures CFTR to potentiate autophagosomal clearance under stress","volume":"35","author":"Arora","year":"2021","journal-title":"FASEB J"},{"key":"2024102012242280000_61.4.2300216.17","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1164\/rccm.202106-1426OC","article-title":"Trikafta rescues CFTR and lowers monocyte P2X7R-induced inflammasome activation in cystic fibrosis","volume":"205","author":"Gabillard-Lefort","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102012242280000_61.4.2300216.18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-22558-5"},{"key":"2024102012242280000_61.4.2300216.19","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1203\/PDR.0b013e31822f2448","article-title":"Calcium modulated chloride pathways contribute to chloride flux in murine CF-affected macrophages","volume":"70","author":"Shenoy","year":"2011","journal-title":"Pediatr Res"},{"key":"2024102012242280000_61.4.2300216.20","doi-asserted-by":"crossref","unstructured":"Goriounova AS , Gilmore RC , Wrennall JA , et al. Super resolution microscopy analysis reveals increased Orai1 activity in asthma and cystic fibrosis lungs. J Cyst Fibros 2022; in press [https:\/\/doi.org\/10.1016\/j.jcf.2022.07.003]. doi:10.1016\/j.jcf.2022.07.003","DOI":"10.1016\/j.jcf.2022.07.003"},{"key":"2024102012242280000_61.4.2300216.21","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2008-0170OC"},{"key":"2024102012242280000_61.4.2300216.22","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202004-0991OC"},{"key":"2024102012242280000_61.4.2300216.23","doi-asserted-by":"crossref","first-page":"111797","DOI":"10.1016\/j.celrep.2022.111797","article-title":"Recruited monocytes\/macrophages drive pulmonary neutrophilic inflammation and irreversible lung tissue remodeling in cystic fibrosis","volume":"41","author":"Oz","year":"2022","journal-title":"Cell Rep"},{"key":"2024102012242280000_61.4.2300216.24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26777-9"},{"key":"2024102012242280000_61.4.2300216.25","doi-asserted-by":"publisher","DOI":"10.1172\/JCI125669"},{"key":"2024102012242280000_61.4.2300216.26","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201609-1954OC"},{"key":"2024102012242280000_61.4.2300216.27","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1513\/AnnalsATS.201907-493OC","article-title":"changes in airway microbiome and inflammation with ivacaftor treatment in patients with cystic fibrosis and the G551D mutation","volume":"17","author":"Harris","year":"2020","journal-title":"Ann Am Thorac Soc"},{"key":"2024102012242280000_61.4.2300216.28","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00318-2019"},{"key":"2024102012242280000_61.4.2300216.29","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/ppul.26261","article-title":"Impact of elexacaftor-tezacaftor-ivacaftor on bacterial colonization and inflammatory responses in cystic fibrosis","volume":"58","author":"Sheikh","year":"2023","journal-title":"Pediatr Pulmonol"},{"key":"2024102012242280000_61.4.2300216.30","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jcf.2015.02.010","article-title":"Alterations in blood leukocytes of G551D-bearing cystic fibrosis patients undergoing treatment with ivacaftor","volume":"15","author":"Bratcher","year":"2016","journal-title":"J Cyst Fibros"},{"key":"2024102012242280000_61.4.2300216.31","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1165\/rcmb.2019-0032OC","article-title":"Transcriptomic responses to ivacaftor and prediction of ivacaftor clinical responsiveness","volume":"61","author":"Sun","year":"2019","journal-title":"Am J Respir Cell Mol Biol"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.00216-2023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T06:22:19Z","timestamp":1740378139000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.00216-2023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":31,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4,1]]},"published-print":{"date-parts":[[2023,4]]}},"alternative-id":["10.1183\/13993003.00216-2023"],"URL":"https:\/\/doi.org\/10.1183\/13993003.00216-2023","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4]]}}}